These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10376936)

  • 1. Schmidt-Lanterman's incisures--the principal target of autoimmune attack in demyelinating Guillain-Barré syndrome?
    Görtzen A; Schlüter S; Veh RW
    J Neuroimmunol; 1999 Feb; 94(1-2):58-65. PubMed ID: 10376936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Yuki N; Tagawa Y; Handa S
    J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
    Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
    J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
    Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
    J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
    J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy.
    Vedeler CA; Matre R; Nyland H
    Acta Neurol Scand; 1988 Nov; 78(5):401-7. PubMed ID: 2464267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of antiglycolipid antibodies.
    Baumann N
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):31-40. PubMed ID: 11064824
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    McCombe PA; Pollard JD; McLeod JG
    Clin Exp Neurol; 1988; 25():53-60. PubMed ID: 3267485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies.
    Pestronk A; Choksi R; Yee WC; Kornberg AJ; Lopate G; Trotter J
    J Neuroimmunol; 1998 Nov; 91(1-2):204-9. PubMed ID: 9846837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation.
    Koski CL
    Ann N Y Acad Sci; 1987; 505():319-25. PubMed ID: 3479928
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
    J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody.
    Molander M; Berthold CH; Persson H; Andersson K; Fredman P
    J Neurocytol; 1997 Feb; 26(2):101-11. PubMed ID: 9181484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome.
    Steck AJ; Schaeren-Wiemers N; Hartung HP
    Curr Opin Neurol; 1998 Aug; 11(4):311-8. PubMed ID: 9725076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between autoantibody specificities and peripheral nervous system involvements.
    Jauberteau-Marchan MO
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):41-9. PubMed ID: 11064825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.